Nahla S. Barakat

788 total citations
32 papers, 658 citations indexed

About

Nahla S. Barakat is a scholar working on Pharmaceutical Science, Analytical Chemistry and Biomaterials. According to data from OpenAlex, Nahla S. Barakat has authored 32 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmaceutical Science, 6 papers in Analytical Chemistry and 5 papers in Biomaterials. Recurrent topics in Nahla S. Barakat's work include Advanced Drug Delivery Systems (23 papers), Drug Solubulity and Delivery Systems (18 papers) and Advancements in Transdermal Drug Delivery (9 papers). Nahla S. Barakat is often cited by papers focused on Advanced Drug Delivery Systems (23 papers), Drug Solubulity and Delivery Systems (18 papers) and Advancements in Transdermal Drug Delivery (9 papers). Nahla S. Barakat collaborates with scholars based in Saudi Arabia, Egypt and United States. Nahla S. Barakat's co-authors include Alanood S. Almurshedi, Ibrahim Elbagory, Alaa Eldeen B. Yassin, Amany A.E. Ahmed, Mahmoud El‐Badry, Mahasen A. Radwan, Saied Belal, Rim S. Haggag, Ehab A. Fouad and Gamal A. Shazly and has published in prestigious journals such as Journal of Pharmacy and Pharmacology, Journal of Pharmaceutical and Biomedical Analysis and Nanomedicine.

In The Last Decade

Nahla S. Barakat

32 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nahla S. Barakat Saudi Arabia 17 438 110 99 81 68 32 658
Yvonne Tze Fung Tan Malaysia 16 371 0.8× 79 0.7× 82 0.8× 118 1.5× 81 1.2× 42 736
Madhusudan Rao Yamsani India 17 666 1.5× 95 0.9× 78 0.8× 129 1.6× 99 1.5× 56 936
Shivanand P. Puthli India 10 506 1.2× 66 0.6× 116 1.2× 85 1.0× 80 1.2× 14 772
Srikonda V. Sastry United States 10 450 1.0× 144 1.3× 81 0.8× 104 1.3× 51 0.8× 13 812
Sajeev Chandran India 14 358 0.8× 102 0.9× 66 0.7× 80 1.0× 83 1.2× 24 653
Vijay B. Sutariya India 11 370 0.8× 65 0.6× 138 1.4× 101 1.2× 126 1.9× 16 749
M. Efentakis Greece 17 571 1.3× 137 1.2× 86 0.9× 65 0.8× 128 1.9× 33 787
Susanne Muschert France 14 305 0.7× 102 0.9× 87 0.9× 37 0.5× 77 1.1× 25 521
Rajan Verma India 8 387 0.9× 120 1.1× 49 0.5× 74 0.9× 30 0.4× 18 560
Rajni Bala India 12 423 1.0× 67 0.6× 124 1.3× 168 2.1× 83 1.2× 38 836

Countries citing papers authored by Nahla S. Barakat

Since Specialization
Citations

This map shows the geographic impact of Nahla S. Barakat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahla S. Barakat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahla S. Barakat more than expected).

Fields of papers citing papers by Nahla S. Barakat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahla S. Barakat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahla S. Barakat. The network helps show where Nahla S. Barakat may publish in the future.

Co-authorship network of co-authors of Nahla S. Barakat

This figure shows the co-authorship network connecting the top 25 collaborators of Nahla S. Barakat. A scholar is included among the top collaborators of Nahla S. Barakat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahla S. Barakat. Nahla S. Barakat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taha, Ehab I., et al.. (2015). Formulation and in vivo evaluation of diclofenac sodium sustained release matrix tablet: effect of compression force.. PubMed. 28(2). 573–9. 1 indexed citations
2.
Barakat, Nahla S., et al.. (2012). Enhancement of Skin Permeation and Anti-Inflammatory Effect of Indomethacin Using Nanoemulsuion. Letters in Drug Design & Discovery. 9(4). 436–446. 6 indexed citations
3.
Barakat, Nahla S., et al.. (2012). Development of Novel Controlled Release Gliclazide-Loaded poly(ε- caprolactone) Microparticles: Effect of Polymer Blends. Pharmaceutica Analytica Acta. 3(3). 5 indexed citations
4.
Barakat, Nahla S., et al.. (2012). Influence of polymer blends on the characterization of gliclazide – encapsulated into poly (Æ-caprolactone) microparticles. Drug Development and Industrial Pharmacy. 39(2). 352–362. 18 indexed citations
5.
Barakat, Nahla S. & Ehab A. Fouad. (2011). Enhancement of skin permeation and anti- inflammatory effect of indomethacin using microemulsion. Asian Journal of Pharmaceutics. 5(3). 141. 6 indexed citations
6.
Hassan, Mohamed A., et al.. (2011). Formulation and in vitro/in vivo evaluation of naproxen mucoadhesive buccal patches for local effect. Journal of Drug Delivery Science and Technology. 21(5). 423–431. 17 indexed citations
7.
Elbagory, Ibrahim, et al.. (2011). Formulation and in vitro evaluation of theophylline matrix tablets prepared by direct compression: Effect of polymer blends. Saudi Pharmaceutical Journal. 20(3). 229–238. 21 indexed citations
8.
Barakat, Nahla S.. (2010). Optimization of physical characterization, skin permeation of naproxen from glycofurol-based topical gel. Asian Journal of Pharmaceutics. 4(2). 154. 9 indexed citations
9.
Barakat, Nahla S.. (2010). Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation. Journal of Pharmacy and Pharmacology. 62(2). 173–180. 30 indexed citations
10.
Barakat, Nahla S., Saleh A. Al‐Suwayeh, Ehab I. Taha, & Alaa Eldeen B. Yassin. (2010). A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma. Journal of drug targeting. 19(5). 365–372. 15 indexed citations
11.
Barakat, Nahla S. & Alanood S. Almurshedi. (2010). Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: In vitro / in vivo evaluation. Journal of Microencapsulation. 28(2). 122–133. 6 indexed citations
12.
Barakat, Nahla S.. (2009). Magnetically Modulated Nanosystems: A Unique Drug-Delivery Platform. Nanomedicine. 4(7). 799–812. 50 indexed citations
13.
Barakat, Nahla S.. (2009). In Vitro and In Vivo Characteristics of a Thermogelling Rectal Delivery System of Etodolac. AAPS PharmSciTech. 10(3). 724–31. 35 indexed citations
14.
Barakat, Nahla S., Ibrahim Elbagory, & Alanood S. Almurshedi. (2008). Formulation, Release Characteristics and Bioavailability Study of Oral Monolithic Matrix Tablets Containing Carbamazepine. AAPS PharmSciTech. 9(3). 931–938. 27 indexed citations
15.
16.
Barakat, Nahla S., Ibrahim Elbagory, & Alanood S. Almurshedi. (2008). Controlled-Release Carbamazepine Granules and Tablets Comprising Lipophilic and Hydrophilic Matrix Components. AAPS PharmSciTech. 9(4). 1054–1062. 27 indexed citations
17.
Yassin, Alaa Eldeen B., et al.. (2008). Preparation and Characterization of Spironolactone-Loaded Gelucire Microparticles Using Spray-Drying Technique. Drug Development and Industrial Pharmacy. 35(3). 297–304. 31 indexed citations
18.
Barakat, Nahla S., et al.. (2008). The influence of various amphiphilic excipients on the physicochemical properties of carbamazepine-loaded microparticles. Journal of Microencapsulation. 26(3). 251–262. 8 indexed citations
19.
Barakat, Nahla S.. (2006). Etodolac-Liquid-Filled Dispersion into Hard Gelatin Capsules: An Approach to Improve Dissolution and Stability of Etodolac Formulation. Drug Development and Industrial Pharmacy. 32(7). 865–876. 27 indexed citations
20.
Barakat, Nahla S. & Mahasen A. Radwan. (2006). In Vitro Performance of Carbamazepine Loaded to Various Molecular Weights of Poly (D, L-Lactide-Co-Glycolide). Drug Delivery. 13(1). 9–18. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvonne Tze Fung Tan Breakdown of academic impact, for papers by Madhusudan Rao Yamsani Breakdown of academic impact, for papers by Shivanand P. Puthli Breakdown of academic impact, for papers by Srikonda V. Sastry Breakdown of academic impact, for papers by Sajeev Chandran Breakdown of academic impact, for papers by Vijay B. Sutariya Breakdown of academic impact, for papers by M. Efentakis Breakdown of academic impact, for papers by Susanne Muschert Breakdown of academic impact, for papers by Rajan Verma Breakdown of academic impact, for papers by Rajni Bala
Rankless by CCL
2026